Vera Therapeutics, Inc.

NASDAQ:VERA

42.6 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 27.25625.08569.10545.68127.44133.889137.38543.45930.47550.427111.50679.67486.19191.62549.50553.654-3.229
Short Term Investments 326.053359.302334.559115.035132.498147.13259.76871.19483.94581.50139.4320.8670.0570.0850.0670.0866.458
Cash and Short Term Investments 353.309384.387403.664160.716159.939181.021197.153114.653114.42131.928150.93879.67486.19191.62549.50553.6543.229
Net Receivables 01.961.63100000000000000
Inventory 000000000000001.8790.4720
Other Current Assets 10.8228.411.07511.30711.6819.5937.29611.04510.56210.416.8052.8633.5694.2512.0270.6070
Total Current Assets 364.131389.503407.923165.543171.62190.614204.449125.698124.982142.338157.74382.53789.7695.87651.53254.2613.229
Non-Current Assets:
Property, Plant & Equipment, Net 4.2892.0842.5133.0413.4814.074.5945.2245.8245.7456.291000000
Goodwill 00000000000000000
Intangible Assets 00000000000000000
Goodwill and Intangible Assets 00000000000000000
Long Term Investments 0000.0110.0130.0290.0570.0580.1220.3240.580.8671.1141.4780.29300
Tax Assets 00000000000000000
Other Non-Current Assets 0.145.7048.926.9510.5040.4650.5040.4550.4420.3750.360.3440.2930.29300.293-3.229
Total Non-Current Assets 4.4297.78811.43310.0033.9984.5645.1555.7376.3886.4447.2311.2111.4071.7710.2930.293-3.229
Total Assets 368.56397.291419.356175.546175.618195.178209.604131.435131.37148.782164.97483.74891.16797.64751.82554.5540
Liabilities & Equity:
Current Liabilities:
Account Payables 4.6024.6645.20911.11812.313.285.32611.9917.0127.0847.3281.3850.9641.7231.440.9090
Short Term Debt 1.8724.2322.2754.8725.0365.125.2042.6455.3784.94.9800000.0020
Tax Payables 00000000000000000
Deferred Revenue 000000000-2.45000000.5330
Other Current Liabilities 19.999.5227.0596.3137.2858.43512.99910.9643.535.2957.6616.3053.0782.0482.3131.4950
Total Current Liabilities 26.46418.41814.54322.30324.62126.83523.52925.615.9217.27919.9697.694.0423.7713.7532.4060
Non-Current Liabilities:
Long Term Debt 53.03850.71850.98551.27227.00427.53328.0828.6419.4469.71310.2944.92300000
Deferred Revenue Non-Current 00000000000000000
Deferred Tax Liabilities Non-Current 00000000000000000
Other Non-Current Liabilities 00.2860.2860.2860.2860.2870.2860.2860.2860.2860.2861.5431.6481.721141.388141.4960
Total Non-Current Liabilities 53.03851.00451.27151.55827.2927.8228.36628.9279.7329.99910.586.4661.6481.721141.388141.4960
Total Liabilities 79.50269.42265.81473.86151.91154.65551.89554.52725.65227.27830.54914.1565.695.492145.141143.9020
Equity:
Preferred Stock 00000000000091.16797.647139.576139.57640.095
Common Stock 0.0550.0550.0540.0440.0440.0440.0440.0280.0280.0270.0270.0210.0210.021000
Retained Earnings -417.825-371.193-337.485-309.102-283.447-263.343-243.181-213.112-180.673-155.994-141.141-124.056-107.209-99.598-96.161-91.4470
Accumulated Other Comprehensive Income/Loss 1.044-0.45-0.1730.251-0.075-0.142-0.004-0.224-0.279-0.152-0.012-0-91.167-97.64700-36.548
Other Total Stockholders Equity 705.784699.457691.146410.492407.185403.964400.85290.216286.642277.623275.551193.627283.832191.7322.845-137.4770
Total Shareholders Equity 289.058327.869353.542101.685123.707140.523157.70976.908105.718121.504134.42569.59285.47792.155-93.316-89.3483.547
Total Equity 289.058327.869353.542101.685123.707140.523157.70976.908105.718121.504134.42569.59285.47792.155-93.316-89.3483.547
Total Liabilities & Shareholders Equity 368.56397.291419.356175.546175.618195.178209.604131.435131.37148.782164.97483.74891.16797.64751.82554.5543.547